Enochian BioSciences annuncia la presentazione scientifica del caso di un soggetto affetto da HIV con livelli controllati di virus nel sangue per 255 giorni in seguito al trattamento con una nuova terapia cellulare
May 14, 2021 15:19 ET
|
Enochian Bioscience
LOS ANGELES, May 14, 2021 (GLOBE NEWSWIRE) -- Enochian BioSciences, Inc., un’azienda specializzata in terapie cellulari e immunitarie basate su geni modificati per la cura di malattie infettive e...
Enochian BioSciences kondigt een wetenschappelijke presentatie aan van een persoon met HIV met vertoning van gecontroleerde bloedniveaus van de virus gedurende 255 dagen na de behandeling met een Novel Cellular Therapy
May 14, 2021 15:19 ET
|
Enochian Bioscience
LOS ANGELES, May 14, 2021 (GLOBE NEWSWIRE) -- Enochian BioSciences Inc., een bedrijf dat zich richt op genetisch gemodificeerde cellulaire en immuuntherapieën bij infectieziekten en kanker, kondigde...
Enochian BioSciences announces Scientific Presentation of a Person with HIV Exhibiting Controlled Blood Levels of Virus for 255 Days Following Treatment with a Novel Cellular Therapy
May 12, 2021 16:29 ET
|
Enochian Biosciences, Inc.
LOS ANGELES, May 12, 2021 (GLOBE NEWSWIRE) -- Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced the...
Enochian BioSciences announces Scientific Presentation of a Person with HIV Exhibiting Controlled Blood Levels of Virus for 255 Days Following Treatment with a Novel Cellular Therapy
May 12, 2021 08:00 ET
|
Enochian Biosciences, Inc.
LOS ANGELES, May 12, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today...
Seraph Research Institute and Enochian BioSciences Publish a Case Report of Complete Remission of Recurrent Glioblastoma with Innovative Therapy
March 24, 2021 18:00 ET
|
Enochian Biosciences, Inc.
LOS ANGELES, March 24, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Seraph Research Institute (SRI) and Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in...
Enochian BioSciences to Present to Investors at the H.C. Wainwright Global Life Sciences Conference
February 22, 2021 17:15 ET
|
Enochian Biosciences, Inc.
LOS ANGELES, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Enochian BioSciences, a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that it will...
Enochian BioSciences to Present to Investors at 22nd Annual H.C. Wainwright Global Investment Conference
September 10, 2020 00:50 ET
|
Enochian Biosciences, Inc.
LOS ANGELES, Sept. 10, 2020 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) − Enochian BioSciences, a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today...
Distinguished Scientific Leaders to Join Enochian BioSciences Hepatitis B Scientific Advisory Board
July 27, 2020 08:00 ET
|
Enochian Biosciences, Inc.
Drs. Carol Brosgart, Peter Revill and Fabien Zoulim will advise on development of a cure for Hepatitis B LOS ANGELES, July 27, 2020 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) − Enochian BioSciences, a...
Enochian BioSciences Announces Its Successful Completion of FDA INTERACT Meeting for a Potential Cure for HIV
June 08, 2020 07:30 ET
|
Enochian Biosciences, Inc.
Company encouraged by strong alignment with views of FDA’s CBER regarding ENOB-HV-01LOS ANGELES, June 08, 2020 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) - Enochian BioSciences, Inc., a company focused on...
Enochian Biosciences Announces Three Scientific Presentations on Potential HIV and HBV Cures
May 13, 2020 08:00 ET
|
Enochian Biosciences, Inc.
• First presentation of a novel approach to potentially cure HIV - An in vivo study demonstrated a 164 percent increase in engraftment of genetically modified cells Poster Presentation -...